Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Shah2020 - Predicting Human Liver Microsomal Stability of small molecules

ABSTRACT: The Human Liver Microsomal assay takes into account the liver-mediated drug metabolism to assess the stability of a compound in the human body. The NIH-NCATS group took a proprietary dataset of 4300 compounds with its associated HLM (in vitro half-life; unstable ≤ 30 min, stable >30 min) and used it to train a classifier. Model Type: Machine learning model. Model Relevance: Probability of a compound being unstable in a HLM assay. Model Encoded by: Pauline Banye (Ersilia) Metadata Submitted in BioModels by: Zainab Ashimiyu-Abdusalam Implementation of this model code by Ersilia is available here: https://github.com/ersilia-os/eos31ve

SUBMITTER: Zainab Ashimiyu-Abdusalam

PROVIDER: MODEL2405130005 | BioModels | 2024-05-13

REPOSITORIES: BioModels

ACCESS DATA

Json Xml

Publications

Predicting liver cytosol stability of small molecules.

Shah Pranav P Siramshetty Vishal B VB Zakharov Alexey V AV Southall Noel T NT Xu Xin X Nguyen Dac-Trung DT

Journal of cheminformatics 20200407 1

Over the last few decades, chemists have become skilled at designing compounds that avoid cytochrome P (CYP) 450 mediated metabolism. Typical screening assays are performed in liver microsomal fractions and it is possible to overlook the contribution of cytosolic enzymes until much later in the drug discovery process. Few data exist on cytosolic enzyme-mediated metabolism and no reliable tools are available to chemists to help design away from such liabilities. In this study, we screened 1450 co ...[more]

PMID: 33431020

Similar Datasets

Siramshetty2020 - Assessment of rat liver microsomal stability with QSAR models.

Project description:Hepatic metabolic stability is key to ensure the drug attains the desired concentration in the body. The Rat Liver Microsomal (RLM) stability is a good approximation of a compound’s stability in the human body, and NCATS has collected a proprietary dataset of 20216 compounds with its associated RLM (in vitro half-life; unstable ≤30 min, stable >30 min) and used it to train a classifier based on an ensemble of several ML approaches (random forest, deep neural networks, graph convolutional neural networks and recurrent neural networks. Model Type: Predictive machine learning model. Model Relevance: Predicting the stability of a compound in RLM assay. Model Encoded by: Pauline (Ersilia) Metadata Submitted in BioModels by: Zainab Ashimiyu-Abdusalam Implementation of this model code by Ersilia is available here: https://github.com/ersilia-os/eos5505

2024-04-22 | MODEL2404220002 | BioModels

Shah2020 - Predicting liver cytosol stability of small molecules.

Project description:The human liver cytosol stability model is used for predicting the stability of a drug in the cytosol of human liver cells, which is beneficial for identifying potential drug candidates early during the drug discovery process. If a drug compound is quickly absorbed, it may not reach the intended target in the body or become toxic. On the other hand, if a drug compound is too stable, it could accumulate and cause detrimental effects. The authors use an NCATS dataset of 1450 compounds screened in vitro in mouse and human cytosol fractions. Compounds were classified as stable (half-life > 30min) or unstable (half-life ≤ 30 min). Note that authors report the dataset was biased towards stable compounds. Model Type: Machine learning model. Model Relevance: Predicts probability of a compound stability due to liver cells metabolism. Model Encoded by: Pauline (Ersilia) Metadata Submitted in BioModels by: Zainab Ashimiyu-Abdusalam Implementation of this model code by Ersilia is available here: https://github.com/ersilia-os/eos9yy1

2024-04-22 | MODEL2404220005 | BioModels

Sun2019 - Predictive models of aqueous solubility of organic compounds.

Project description:Kinetic aqueous solubility (μg/mL) was experimentally determined using the same SOP in over 200 NCATS drug discovery projects. A final dataset of 11780 non-redundant molecules and their associated solubility was used to train a SVM classifier. Model Type: Predictive machine learning model. Model Relevance: Predicting the aqueous solubility of a chemical compound. Model Encoded by: Pauline (Ersilia) Metadata Submitted in BioModels by: Zainab Ashimiyu-Abdusalam Implementation of this model code by Ersilia is available here: https://github.com/ersilia-os/eos74bo

2024-04-22 | MODEL2404220003 | BioModels

Sun2017 - predictive and interpretable models for PAMPA permeability 7

Project description:Parallel Artificial Membrane Permeability is an in vitro surrogate to determine the permeability of drugs across cellular membranes. PAMPA at pH 7.4 was experimentally determined in a dataset of 5,473 unique compounds by the NIH-NCATS. 50% of the dataset was used to train a classifier (SVM) to predict the permeability of new compounds, and validated on the remaining 50% of the data, rendering an AUC = 0.88. The Peff was converted to logarithmic, log Peff value lower than 2.0 were considered to have low to moderate permeability, and those with a value higher than 2.5 were considered as high-permeability compounds. Model Type: Predictive machine learning model. Model Relevance: The model predicts a chemical compound as highly or low/moderate permeable. Model Encoded by: Pauline (Ersilia) Metadata Submitted in BioModels by: Zainab Ashimiyu-Abdusalam Implementation of this model code by Ersilia is available here: https://github.com/ersilia-os/eos9tyg

2024-04-23 | MODEL2404220001 | BioModels

Williams2022 - Permeable compound selection using in vitro ADME data (PAMPA pH 5).

Project description:Parallel Artificial Membrane Permeability is an in vitro surrogate to determine the permeability of drugs across cellular membranes. PAMPA at pH 5 was experimentally determined in a dataset of 5,473 unique compounds by the NIH-NCATS. 50% of the dataset was used to train a classifier (SVM) to predict the permeability of new compounds, and validated on the remaining 50% of the data, rendering an AUC = 0.88. The Peff was converted to logarithmic, log Peff value lower than 2.0 were considered to have low to moderate permeability, and those with a value higher than 2.5 were considered as high-permeability compounds. Model Type: Predictive machine learning model. Model Relevance: Predicting compound permeability across cellular membranes. Model Encoded by: Pauline Banye (Ersilia) Metadata Submitted in BioModels by: Zainab Ashimiyu-Abdusalam Implementation of this model code by Ersilia is available here: https://github.com/ersilia-os/eos81ew

2024-04-22 | MODEL2404220004 | BioModels

Stokes2020 - Antibiotics discovery using deep learning approach.

Project description:Based on a simple E.coli growth inhibition assay, the authors trained a model capable of identifying antibiotic potential in compounds structurally divergent from conventional antibiotic drugs. One of the predicted active molecules, Halicin (SU3327), was experimentally validated in vitro and in vivo. Model Type: Predictive machine learning model. Model Relevance: Probability that a compound inhibits E.coli growth. Model Encoded by: Miquel Duran-Frigola(Ersilia) Metadata Submitted in BioModels by: Zainab Ashimiyu-Abdusalam Implementation of this model code by Ersilia is available here: https://github.com/ersilia-os/eos4e40

2024-04-22 | MODEL2404080001 | BioModels

KC2021 - A machine learning platform to estimate anti-SARS-CoV-2 activities

Project description:Predictor of several endpoints related to Sars-CoV-2. It provides predictions for Live Virus Infectivity, Viral Entry, Viral Replication, In Vitro Infectivity and Human Cell Toxicity using a combination of three models. Consensus results are obtained by averaging the prediction for the three different models for each activity and toxicity models. The models have been built using NCATS COVID19 data. Model Type: Predictive machine learning model. Model Relevance: Predicts activity of compound in COVID assay. Model Encoded by: Pradnya (Ersilia) Metadata Submitted in BioModels by: Zainab Ashimiyu-Abdusalam Implementation of this model code by Ersilia is available here: https://github.com/ersilia-os/eos8fth

2024-05-13 | MODEL2405130004 | BioModels

Saccharomyces cerevisiae

Project description:Oxidative Stress 30-min interval

| PRJNA93823 | ENA

Ischemic Pre- and Post Conditioning has pronounced effects on Gene Expression Profiles in the Rat Liver after Ischemia/Reperfusion

Project description:Ischemia/reperfusion injuries is a known complication to hepatic surgery. Ischemic pre- (IPC) and postconditioning (IPO) protects the liver against ischemia/reperfusion-injuries. Expression profiling were performed on liver biopsies seeking to identify molecular mediators of the protective properties. 48 rats were divided into 5 groups; sham (n=8), IRI (n=10), IPC (n=10), IPO (n=10) and IPC+IPO (n=10). All rats except sham rats were subjected to 30 min of total liver ischemia and 30 min of reperfusion before liver biopsies were sampled. In the IPC group, liver ischemia was preceded by 10 min of hepatic ischemia, followed by 10 min of reperfusion. IPO were performed by three cycles of 30 sec of reperfusion and 30 sec of ischemia, applied immediately after the 30 min of total liver ischemia. In the IPC+IPO group the two interventions were combined.

2011-09-30 | E-GEOD-24430 | biostudies-arrayexpress

Microarray analysis of RNA stability in mouse Neuro-2A cells

Project description:Cells were grown to ~50% confluency before RNA polymerase activity was blocked with 10 µg/mL Actinomycin D (Sigma) in DMSO. Control cells were treated with DMSO alone. Transcriptional inhibition of N2A cells was conducted for 32 h with cells harvested at time zero (0 h) and after 30 min, 2, 4, 8, 16 and 32 h. Inhibition of 3T3 cells was conducted for 24 h with harvesting at time zero (0 h) and after 30 min, 2, 4, 8 and 24 h.

2012-01-24 | E-MTAB-961 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data